Advertisement

Neurotoxicity Research

, Volume 36, Issue 3, pp 441–451 | Cite as

Panax notoginsenoside Rb1 Restores the Neurotrophic Imbalance Following Photothrombotic Stroke in Rats

  • Chun-Yan Yang
  • Jian-Yu Yang
  • Yun-Xia Xiong
  • Xue-Feng Zhuang
  • Hui Su
  • Sheng Hu
  • Jia-Qing Ma
  • Xin-Fu Zhou
  • Hai-Yun LuoEmail author
  • Jun SunEmail author
Original Article
  • 88 Downloads

Abstract

Mature brain-derived neurotrophic factor (mBDNF) has neuroprotection in cerebral ischemia. Conversely, the precursor of brain-derived neurotrophic factor (proBDNF) has the opposite function to its mature form, inducing apoptosis. However, whether the neuroprotection of Panax notoginsenoside Rb1 (PNS-Rb1) on ischemic stroke is due to, at least partially, its modulation of suppressing proBDNF/P75NTR/sortilin or upregulation of mBDNF is not clear. To test this hypothesis, rats induced by photothrombotic stroke were treated with PNS-Rb1 100 mg/kg or nimodipine 1 mg/kg twice a day until 3, 7, and 14 days. Our data indicate that PNS-Rb1 significantly reduced cerebral infarction rate, proBDNF/P75NTR/sortilin, and plasminogen activator inhibitor-1 (PAI-1) protein levels, and improved sensorimotor dysfunctions induced by ischemic stroke, upregulation of BDNF/TrkB levels, and its processing enzymes (tissue plasminogen activator, tPA) in a time-dependent manner. Taken together, our findings indicate that the improvement of sensorimotor dysfunctions by PNS-Rb1 following ischemic stroke is made, at least partially, by activating the BDNF/TrkB and inhibiting proBDNF/sortilin/P75NTR.

Keywords

Panax notoginsenoside Rb1 Photothrombosis BDNF TrkB proBDNF 

Notes

Author Contribution Statements

Study design: HY Luo and J Sun. Study conduct: CY Yang and JY Yang. Data collection: YX Xiong. Data analysis: H Su, S Hu, and XF Zhuang. Data interpretation: JQ Ma. Drafting manuscript: CY Yang and HY Luo. Revising manuscript content: XF Zhou. All authors have read and approved the final submitted manuscript.

Funding Information

This work was supported by the National Natural Science Foundation of China (81760064), Yunnan Applied Basic Research Project(2019FA040), Joint Special Fund Project of Yunnan Provincial Science and Technology Department-Kunming Medical University (2017FE467-025, 160, 163, 2017FE468-135, U012017515, and 2018FE001(-162)), Scientific Research Fund of Yunnan Provincial Education Department (2015Y180), and Innovative Experimental Program for Undergraduates in Kunming Medical University.

Compliance with Ethical Standards

All experimental procedures involving animals were approved by the Animal Ethics Committee of Kunming Medical University and conducted between 7 a.m. and 7 p.m. in accordance with the guidelines of the National Health and Medical Research Council of China. Rats were acclimatized for a week before any procedures were initiated.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Barker PA (2009) Whither proBDNF? Nat Neurosci 12(2):105–106.  https://doi.org/10.1038/nn0209-105 CrossRefGoogle Scholar
  2. Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P, Freret T (2009) The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc 4:1560–1564.  https://doi.org/10.1038/nprot.2009.125 CrossRefGoogle Scholar
  3. Cao W, Duan J, Wang X, Zhong X, Hu Z, Huang F et al (2014) Early enriched environment induces an increased conversion of proBDNF to BDNF in the adult rat's hippocampus. Behav Brain Res. 265:76-83.  https://doi.org/10.1016/j.bbr.2014.02.022
  4. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005–1011CrossRefGoogle Scholar
  5. Choi Y, Kang SG, Kam KY (2015) Changes in the BDNF-immunopositive cell population of neocortical layers I and II/III after focal cerebral ischemia in rats. Brain Res 1605:76–82.  https://doi.org/10.1016/j.brainres.2015.02.007 CrossRefGoogle Scholar
  6. Coulson EJ, Reid K, Baca M, Shipham KA, Hulett SM, Kilpatrick TJ, Bartlett PF (2000) A new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J Biol Chem 275:30537–30545CrossRefGoogle Scholar
  7. Coulson EJ, Reid K, Shipham KM, Morley S, Kilpatrick TJ et al (2004) The role of neurotransmission and the chopper domain in p75 neurotrophin receptor death signaling. Prog Brain Res 146:41–62CrossRefGoogle Scholar
  8. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet (London, England) 371:1612–1623.  https://doi.org/10.1016/S0140-6736(08)60694-7 CrossRefGoogle Scholar
  9. Fan YJ, Wu LL, Li HY, Wang YJ, Zhou XF (2008) Differential effects of pro-BDNF on sensory neurons after sciatic nerve transection in neonatal rats. Eur J Neurosci 27:2380–2390.  https://doi.org/10.1111/j.1460-9568.2008.06215.x CrossRefGoogle Scholar
  10. Hashimoto K (2013) Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol 100:15–29.  https://doi.org/10.1016/j.pneurobio.2012.09.001 CrossRefGoogle Scholar
  11. Hashimoto K (2016) Regulation of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain by serotonin. Eur Arch Psychiatry Clin Neurosci 266:195–197.  https://doi.org/10.1007/s00406-016-0682-9 CrossRefGoogle Scholar
  12. Hempstead BL (2014) Deciphering proneurotrophin actions. Handb Exp Pharmacol 220:17–32.  https://doi.org/10.1007/978-3-642-45106-5_2 CrossRefGoogle Scholar
  13. Hermann DM, Chopp M (2012) Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 11:369–380.  https://doi.org/10.1016/S1474-4422(12)70039-X CrossRefGoogle Scholar
  14. Hou J, Xue J, Lee M, Yu J, Sung C (2014) Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int J Mol Med 33:234–240.  https://doi.org/10.3892/ijmm.2013.1552 CrossRefGoogle Scholar
  15. Huang XP, Ding H, Lu JD, Tang YH, Deng BX, Deng CQ (2015) Effects of the combination of the main active components of Astragalus and Panax notoginseng on inflammation and apoptosis of nerve cell after cerebral ischemia-reperfusion. Am J Chin Med 43:1419–1438.  https://doi.org/10.1142/S0192415X15500809 CrossRefGoogle Scholar
  16. Je HS, Yang F, Ji Y, Potluri S, Fu XQ, Luo ZG, Nagappan G, Chan JP, Hempstead B, Son YJ, Lu B (2013) ProBDNF and mature BDNF as punishment and reward signals for synapse elimination at mouse neuromuscular junctions. J Neurosci 33(24):9957–9962.  https://doi.org/10.1523/JNEUROSCI.0163-13.2013 CrossRefGoogle Scholar
  17. Lawrence DA, Strandberg L, Ericson J, Ny T (1990) Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants. J Biol Chem 265:20293–20301Google Scholar
  18. Lee CH, Kim JH (2014) A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 38:161–166.  https://doi.org/10.1016/j.jgr.2014.03.001 CrossRefGoogle Scholar
  19. Li JY, Liu J, Manaph NPA, Bobrovskaya L, Zhou XF (2017) ProBDNF inhibits proliferation, migration and differentiation of mouse neural stem cells. Brain Res. 1668:46–55.  https://doi.org/10.1016/j.brainres.2017.05.013
  20. Liepinsh E, Ilag LL, Otting G, Ibáñez CF (1997) NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J 16(16):4999–5005Google Scholar
  21. Liu XY, Zhou XY, Hou JC, Zhu H, Wang Z, Liu JX, Zheng YQ (2015) Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway. Acta Pharmacol Sin 36:421–428.  https://doi.org/10.1038/aps.2014.156 CrossRefGoogle Scholar
  22. Masumu M, Hata R (2003) Recent advances in adenovirus-mediated gene therapy for cerebral ischemia. Curr Gene Ther 3:43–48CrossRefGoogle Scholar
  23. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE, Hempstead BL, Petersen CM (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427:843–848CrossRefGoogle Scholar
  24. Ong WY, Farooqui T, Koh HL, Farooqui AA, Ling EA (2015) Protective effects of ginseng on neurological disorders. Front Aging Neurosci 7:129.  https://doi.org/10.3389/fnagi.2015.00129 CrossRefGoogle Scholar
  25. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K et al (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306(5695):487–491.  https://doi.org/10.1126/science.1100135 CrossRefGoogle Scholar
  26. Rahman M, Luo H, Sims NR, Bobrovskaya L, Zhou XF (2018) Investigation of mature BDNF and proBDNF signaling in a rat photothrombotic ischemic model. Neurochem Res 43(3):637–649.  https://doi.org/10.1007/s11064-017-2464-9 CrossRefGoogle Scholar
  27. Roza G s, Guerra MJ, Labandeira-Garcia JL (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Protocol 2:75–84CrossRefGoogle Scholar
  28. Seidah NG, Chretien M (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848(1–2):45–62CrossRefGoogle Scholar
  29. Sun Y, Lim Y, Li F, Liu S, Lu JJ, Haberberger R, Zhong JH, Zhou XF (2012) ProBDNF collapses neurite outgrowth of primary neurons by activating RhoA. PLoS One 7(4):e35883.  https://doi.org/10.1371/journal.pone.0035883 CrossRefGoogle Scholar
  30. Tachikawa KK, Harada K, Kashimoto T, Miyate Y et al (1999) Effects of ginseng saponins on responses induced by various receptor stimuli. Eur J Pharmacol 369:23–32CrossRefGoogle Scholar
  31. Tao J, Chen B, Gao Y, Yang S, Huang J, Jiang X, Wu Y, Peng J, Hong Z, Chen L (2014) Electroacupuncture enhances hippocampal NSCs proliferation in cerebral ischemia-reperfusion injured rats via activation of notch signaling pathway. Int J Neurosci 124:204–212.  https://doi.org/10.3109/00207454.2013.840781 CrossRefGoogle Scholar
  32. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, Kraemer RT, Nykjaer A, Hempstead BL (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25:5455–5463CrossRefGoogle Scholar
  33. Wong I, Liao H, Bai X, Zaknic A, Zhong J, Guan Y, Li HY, Wang YJ, Zhou XF (2010) ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury. Brain Behav Immun 24:585–597.  https://doi.org/10.1016/j.bbi.2010.01.001 CrossRefGoogle Scholar
  34. Xu ZQ, Sun Y, Li HY, Lim Y, Zhong JH, Zhou XF (2011) Endogenous proBDNF is a negative regulator of migration of cerebellar granule cells in neonatal mice Eur J Neurosci 33:1376–1384  https://doi.org/10.1111/j.1460-9568.2011.07635.x
  35. Yan YT, Li SD, Li C, Xiong YX, Lu XH, Zhou XF, Yang LQ, Pu LJ, Luo HY (2018) Panax notoginsenoside saponins Rb1 regulates the expressions of Akt/ mTOR/PTEN signals in the hippocampus after focal cerebral ischemia in rats. Behav Brain Res 345:83–92.  https://doi.org/10.1016/j.bbr.2018.02.037 CrossRefGoogle Scholar
  36. Yang J, Harte-Hargrove LC, Siao CJ, Marinic T, Clarke R, Ma Q, Jing D, LaFrancois JJ, Bath KG, Mark W, Ballon D, Lee FS, Scharfman HE, Hempstead BL (2014) proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 7:796–806.  https://doi.org/10.1016/j.celrep.2014.03.040 CrossRefGoogle Scholar
  37. Ye R, Han J, Kong X, Zhao L, Cao R, Rao Z, Zhao G (2008) Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol Pharm Bull 31:1923–1927CrossRefGoogle Scholar
  38. Ye R, Li N, Han J, Kong X, Cao R, Rao Z, Zhao G (2009) Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 64:306–310.  https://doi.org/10.1016/j.neures.2009.03.016 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Chun-Yan Yang
    • 1
  • Jian-Yu Yang
    • 1
  • Yun-Xia Xiong
    • 1
  • Xue-Feng Zhuang
    • 1
  • Hui Su
    • 1
  • Sheng Hu
    • 1
  • Jia-Qing Ma
    • 2
  • Xin-Fu Zhou
    • 3
  • Hai-Yun Luo
    • 1
    Email author
  • Jun Sun
    • 4
    Email author
  1. 1.Department of Pharmacology, College of Basic MedicineKunming Medical UniversityKunmingPeople’s Republic of China
  2. 2.Department of Basic Medical Experiment, College of Basic MedicineKunming Medical UniversityKunmingPeople’s Republic of China
  3. 3.School of Pharmacy and Medical Sciences, Sansom InstituteUniversity of South AustraliaAdelaideAustralia
  4. 4.Department of Anatomy, College of Basic MedicineKunming Medical UniversityKunmingPeople’s Republic of China

Personalised recommendations